This half-day event held October 13, 2012, and sponsored by EMBRACE (Ending Metastatic Breast Cancer for Everyone) was open to all patients with metastatic breast cancer and their families. Participants heard from experts, asked questions, and met others in similar circumstances.
Agenda and Webcast
Webcast, Part 1 (8:30-10 a.m.)
Nancy Lin, MDWelcome and introduction to conference
Davinia Seah, MD, MPHNeeds assessment from EMBRACE study
Eric Winer, MD and Erica Mayer, MD, MPHWhat’s new in metastatic breast cancer
Webcast, Part 2 (10:30 a.m.- noon)
David Rosenthal, MDIntegrative therapies: An evolving discipline
Inez Vas Luis, MDLong-term responders in advanced HER-2 breast cancer
Nikhil Wagle, MDUsing cancer genomics to explain long-term responses in breast cancer
Elgene Lim, MDFunctional research studies utilizing patient-derived breast tissue
Ending Metastatic Breast Cancer for Everyone (EMBRACE) is the name of a research study being conducted at Dana-Farber Cancer Institute. This study began recruiting patients in 2009, with the aim of learning more about the biology of advanced breast cancer, as well as the treatment experiences of patients living with it.
Each patient's progress is tracked by a study coordinator through medical records, and the information collected is used to help doctors understand more about the long-term journey of the metastatic breast cancer patients in this group. Investigators hope the study will bring them closer to finding a cure for metastatic breast cancer.
The study is not sponsored by drug companies, and patients are not required to be on any drug trials.
For more information on EMBRACE, please send an email to firstname.lastname@example.org.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free:
(866) 408-DFCI (3324)